Nite Productions will be hosting the Eff Cancer Benefit on Thursday, Feb. 20. The event will take over McP’s Taphouse from 8 p.m. to midnight with DJ Diversity and special unannounced guests for a ...
Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback